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Abstract 
Background  
Overnutrition and undernutrition can affect patients with inflammatory bowel disease (IBD). 
Although all IBD outpatients should be screened for nutrition risk, screening is not routinely 
performed, potentially leading to reduced identification and treatment. This study aimed to 
estimate the prevalence of nutrition risk in adult IBD outpatients and the proportion of 
cases who discussed diet and/or nutrition during their routine clinical appointment.  
Methods 
Adults with IBD attending outpatient clinics at four hospitals in Greece and in UK were 
recruited. Demographic and anthropometric data were collected using face-to-face patient 
interviews and clinical records. Patients were classified as high (i.e. BMI <18.5kg/m2 or 18.5-
20kg/m2 and weight loss >5%), moderate (i.e. BMI 20-25 kg/m2 and weight loss >5%) or low 
risk of undernutrition and high risk of obesity (i.e. BMI 25-30% and weight gain >5%). The 
proportion of patients who discussed diet and/or nutrition during their clinical appointment 
was calculated.   
 
Results 
In total, 390 IBD patients participated. Sixteen (4%) patients were underweight, 113 (29%) 
were overweight and 71 (18%) were obese. Twenty-one (5%) patients were at high risk of 
undernutrition; of these four (19%) were under dietetic care. Of those at high risk of 
undernutrition, 11 (52%) had discussed diet and/or nutrition during their routine clinical 
appointment. Fifty-six (14%) patients had gained more than 5% weight since their last 
recorded/reported weight and 19 (5%) were at high risk of obesity.  
Conclusions 
Few patients were identified to be at high risk of undernutrition and less than a fifth of 
these were under dietetic care.  Overnutrition is a growing problem in IBD with almost half 
of adult patients being overweight or obese. Diet and/or nutrition were not routinely 
discussed in this group of IBD outpatients. 
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Introduction 
In inflammatory bowel disease (IBD), undernutrition may be caused by reduced oral intake, 
increased gastrointestinal losses, raised nutrient requirements and occasionally, drug-
nutrient interactions 1.  Patients with active Crohn’s disease (CD) are at greatest risk of 
undernutrition, particularly the newly diagnosed 1,2.  
Historically, IBD has been associated with undernutrition, however, in recent years, better 
disease management and the obesity epidemic may have increased the risk of overnutrition. 
Thus, between 15-40% of IBD patients are now reported as overweight or obese 3,4. 
Nutrition screening of all inpatients is mandatory and routinely carried out in the health 
services of certain countries. Such process identifies patients with or at risk of 
undernutrition who will subsequently be referred for comprehensive dietetic assessment 5-7. 
There are few reports of nutrition screening in the IBD outpatient setting 8.  
Beyond the pharmacological management of active disease, nutrition and diet are 
important aspects in the treatment of patients with IBD. However, these are barely 
discussed between clinicians and patients in routine IBD practice 9 and despite the fact that 
three out of the 10 current priorities for all research in IBD are pertinent to diet 10,11. 
The aims of this study were to determine (i) the prevalence of undernutrition and/or 
overnutrition in adult IBD outpatient clinics, (ii) the proportion of patients who discussed 
with their clinician aspects around diet or nutrition, during their recent appointment and (iii) 
the dietetic referral rate for patients identified as at risk of malnutrition by nutrition 
screening.  
 
Methods 
All consecutive patients with CD, ulcerative colitis (UC) or IBD unclassified (IBDU) who 
attended adult outpatient clinics at four hospitals in Greece and UK (Glasgow Royal 
Infirmary, Glasgow, UK; Guy’s and Thomas’ NHS Foundation Trust, London, UK; Ioannina 
General Hospital, Ioannina, Greece; Evangelismos-Ophthalmiatreion Athinon-Polykliniki 
General Hospital, Athens, Greece) over a period of 8 weeks were eligible to take part. 
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Disease diagnosis was ascertained using the European Crohn’s and Colitis Organisation 
diagnostic criteria, including endoscopy with biopsies12. As the majority of patients who 
attend the clinics above suffer from active symptoms or require treatment at hospital (e.g. 
for infusion for biologics) this study was likely to recruit patients with more complicated 
disease.  For all centres included in this study, routine screening for disease associated 
malnutrition was not compulsory in the outpatient setting. 
 
Patients were identified by a member of the clinical team and introduced to the researcher. 
Selection of patients was based on convenience sampling and in a consecutive, unselected 
manner. The researcher verbally introduced the study to the participants and asked if they 
would be willing to answer 5 questions and have their weight and height measured. 
Information on demographics, disease characteristics, medical and nutritional treatment 
were collected from clinical notes and if not available by face-to-face interview with 
patients. Current disease activity was reported by patients, following their clinical 
appointment, as active or in remission. Previous measurements of weight were recorded 
from the clinical notes or were reported by patients. Patients were also asked to report a 
decline in usual intake and weight loss over the past week. Likewise, the number of patients 
who reported any diet and/or nutrition discussion during their clinician appointment was 
recorded (e.g. diet, weight loss or appetite). 
Weight (to the nearest 0.1 kg) and height (to the nearest 0.1cm) were measured using 
standard operating procedures. Using the World Health Organisation criteria for body mass 
index (BMI), underweight was defined as <18.5kg/m2, normal BMI as 18.5-24.9kg/m2, 
overweight as 25-29.9kg/m2 and obesity as > 30kg/m2. To define high risk of undernutrition, 
we used the first two steps of the Malnutrition Universal Screening Tool (MUST), a tool 
widely used in Europe and endorsed for use in the UK, as the third one is more appropriate 
for inpatients 13. Therefore, patients with BMI <18.5kg/m2 or 18.5-20kg/m2 and at least 5% 
concomitant weight loss between current and previous recorded/reported weight were 
classified as high risk of undernutrition as per MUST scoring. This nutrition risk benchmark 
we chose is also in accordance to the consensus statement for the diagnostic criteria of 
malnutrition endorsed by the European Society for Clinical Nutrition and Metabolism 14. 
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Patients with BMI 20-25 kg/m2 and at least 5% weight loss were classified as moderate risk 
of undernutrition. Similarly, overweight patients with at least 5% weight gain were classified 
as high risk of obesity.   
Ethical permission was waived for this study as this was an evaluation of current practice at 
each centre15. 
 
Statistical analysis 
Data are presented with descriptive statistics with differences between groups reported 
using two sample t-test for continuous data (mean (SD)) and chi-squared test for categorical 
data (n (%)). Logistic regression analysis was used to associate risk of malnutrition or obesity 
with demographics and disease characteristics. MINITAB 17 and SPSS 24 were used for 
statistical analysis. Assuming an estimate of 20% of patients classified at high risk of 
undernutrition, with 5% precision and 95% CI, the required sample size is 246 participants. 
 
Results 
In total, 390 patients (CD=247 (63%), UC=127 (33%), IBDU=16 (4%)) were recruited from the 
four centres with 175 (55%) reporting active disease (Table 1). Sixteen (4%) patients were 
underweight, 190 (49%) were normal weight, 113 (29%) were overweight and 71 (18%) 
were obese (Figure 1). Forty-six (12%) patients reported having a reduced intake and 80 
(21%) patients self-reported weight loss. Twenty-seven (7%) patients were under the care of 
the dietitian.  
 
Routine evaluation of nutritional and dietary aspects 
Aspects around diet and/or nutrition were discussed in 135 (35%) patients during their 
clinician appointment. Eighty-nine (23%) patients conveyed a discussion about diet, 91 
(23%) about weight loss and 82 (21%) about their appetite during their recent appointment. 
Two hundred and fifty-five (65%) patients did not discuss any of these aspects. The extent of 
weight loss was significantly higher in patients who had discussed with their clinician aspects 
around diet [discussed: -1.15 kg (6.0) versus not discussed: 0.65 (6.2); p=0.016], weight loss 
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[discussed: -1.65 kg (6.6) versus not discussed: 0.81 kg (6.0); p=0.002], or appetite 
[discussed: -1.62 kg (6.1) versus not discussed: 0.73 kg (6.2); p=0.002]. 
 
Risk of undernutrition  
In total, 21 (5%) patients were at high risk of undernutrition (Figure 1). Of those, only 4 
(19%) were under dietetic care and 11 (52%) discussed diet and/or nutrition in their clinician 
appointment. Twenty-six (7%) patients were screened at moderate risk of undernutrition. 
Of those, only 3 (11%) were under dietetic care and 11 (41%) had a discussion about diet 
and/or nutrition in their clinician appointment. 
Compared to the patients at low risk of undernutrition, the 47 (12%) patients at moderate 
or high risk (combined) were more likely to have a discussion with their clinician about diet 
[moderate/high risk: 17 (35%) versus low risk: 72 (21%); p=0.049], weight loss 
[moderate/high risk: 22 (46%) versus low risk: 69 (20%); p<0.001], or appetite 
[moderate/high risk: 16 (33%) versus low risk: 66 (19%); p=0.050]. The odds ratio for 
clinician appointment discussion about weight loss increased (p=0.002) according to their 
level of undernutrition risk [OR (95% CI): high risk, 3.6 (1.4 to 8.7); moderate risk 3.1 (1.3 to 
7.1)]. Patients at moderate/high risk of undernutrition were younger [moderate/high risk: 
36.2 years (13.9) versus low risk: 41.0 years (14.9); p=0.032] and had a shorter disease 
duration [moderate/high risk: 7.1 years (9.7) versus low risk: 10.8 years (9.7); p=0.012]. 
Patients at moderate/high risk of undernutrition were more likely than those at low risk to 
have active disease [moderate/high risk: 34 (71%) versus low risk: 14 (29%); p<0.001]. 
Neither BMI (r=0.04, p=0.432) nor recent weight loss (r=-0.02, p=0.728) were associated 
with disease duration. There was no difference in the prevalence of high undernutrition risk 
between patients with CD and UC (p=0.809).  
 
Overweight, obesity and risk of obesity      
Fifty six (14%) patients had gained more than 5% weight since their last recorded/reported 
weight. Apart from the 71 (18%) of the patients who were obese, 19 patients (5%) were at 
high risk of obesity. There was no association between obesity or risk of obesity and 
discussion during the clinician appointment about diet, weight loss or appetite. There was a 
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weak positive association between BMI and weight gain (r=0.15, p=0.003) and patients who 
were either obese or at risk of obesity were older [obese/obesity risk: 43.8 years (14.2) 
versus low risk: 39.4 years (14.9); p=0.013]. Disease activity was not associated with obesity 
or risk of obesity. Obesity and risk of obesity did not differ by country (p=0.624) or by IBD 
subtype (p=0.237).  
 
There were no major differences for other nutritional outcomes between centres and as the 
number of patients at high nutrition risk was small, no statistical analysis by centre was 
performed.  
Discussion 
This study in four hospitals from two European countries identified that only 5 and 7% of 
IBD outpatients were at high and moderate risk of undernutrition, respectively. This figure is 
lower than the 27-30% of IBD patients reported at high risk of undernutrition in the 
literature 8,16. The low prevalence of risk of malnutrition observed in the current study is 
likely to be attributed to the enrolment of patients with longstanding disease, in whom 
undernutrition is less common than in newly diagnosed and treatment naïve patients, the 
better disease management nowadays and may be a reflection of the obesity epidemic in 
the general population. In a pooled analysis of 1698 population-based measurement studies 
with 19.2 million participants in 200 countries, trends of obesity increased markedly from 
1975 to 2014 with approximately 25% of the general Greek and UK population classed as 
obese 17. In previous research in CD children, the prevalence of undernutrition dropped 
from 35% at diagnosis to 2% at 24-month follow-up and obesity concomitantly increased 18. 
It is also unlikely that our findings are explained by having oversampled patients in 
remission or with less complicated disease as we enrolled patients attending outpatient 
clinics due to ongoing disease symptoms or biologic infusion clinics, as indicated by the 
characteristics of our sample (Table 1). 
Another important finding of this study is that two-thirds of patients did not discuss diet 
and/or nutrition during their clinician appointment which further supports the argument 
that this aspect of patient care receives less attention than the management of active 
disease 19. Although a small number of patients were at high risk of undernutrition, still in 
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almost half of them (43%) diet and/or nutrition were not discussed, thus risk was not 
identified nor the appropriate care pathway implemented. 
Only 4 (19%) high risk patients were receiving dietetic care, consistent with the findings of 
previous research showing that only 15% to 17% of malnourished outpatients receive 
nutritional treatment 20,21.  This is of concern given that advice on diet is one of the most 
important issues for patients with IBD 10,11,22 and previous authors reported that of those 
who had not seen a dietitian, the vast majority would have liked to 23. 
It is therefore necessary that appropriate action be taken to help increase the frequency of 
nutritional screening in IBD outpatients. One action to overcome barriers with nutritional 
screening would be to program the calculation of BMI, percent weight loss and nutritional 
risk score into IT systems or allowing patients to input this data remotely supporting self-
management; thereby reducing the amount of time the process takes. Patients could be 
given the option to screen at home as an alternative to screening during clinical visits 8,24, 
which would serve not only to reduce the burden on healthcare staff but also empower 
patients to be more involved in their own care 25. However such a process would require 
availability of dietetic resources to formally review high risk cases. 
A drawback of this study is that BMI has limited use to reflect body composition which 
might be a better marker to evaluate the risk of undernutrition and overnutrition in IBD. 
This is particularly important as patients with IBD and undernutrition are more likely to 
present higher levels of adiposity, for the same unit of BMI as healthy controls, are more 
prone to cardiovascular diseases 26,27  and undernutrition can affect adversely their quality 
of life and clinical outcomes 28. In this study, percentage weight loss was determined using 
the current and last recorded weight. Where the last recorded weight was unavailable, 
patients were asked to self-report but this is often normal in routine clinical practice and 
incorporated into nutrition screening tools, e.g. MUST 13,29. Likewise, the timeframe within 
changes in weight were assessed was not specified and it was therefore variable. However, 
both our definition of risk of obesity and undernutrition included patients who were already 
overweight or underweight, based on BMI measurements alone. Information on 
participants’ co-morbidities and other concomitant gastrointestinal diseases was not 
collected but these are unlikely to have influenced the main findings of this study. As this 
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was an appraisal of current clinical practice, dietary assessment was not performed and 
body composition measurements could not be obtained to describe the eating habits of our 
population and the proportion of patients suffering from sarcopenia, obesity or myopenia.  
In conclusion, only 4 in every 100 IBD patients were underweight, while almost half were 
either overweight or obese. Obesity in IBD has been associated with poor disease outcomes 
and patients with IBD are at increased risk of cardiovascular disease 4,27. Therefore, 
provision of weight loss interventions as an adjunctive therapy in these individuals is an area 
that requires further research. 
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Figure legends 
Figure 1: Body mass index and nutrition risk classification    
Athens  Glasgow Ioannina London 
(a) Body mass index (BMI) is classified as underweight <18.5kg/m2, normal 18.5-24.99kg/m2, 
overweight 25-29.99kg/m2, obese >30kg/m2.  
(b) High obesity risk was for patients who were at high risk of obesity and had a BMI>25 and 
at least 5% concomitant weight gain between current and previous recorded/reported 
weight. High risk was for patients at high risk of undernutrition and had a BMI <18.5kg/m2 
or 18.5-20kg/m2 and at least 5% concomitant weight loss between current and previous 
recorded/reported weight. Moderate risk was for patients at moderate risk of 
undernutrition and had a BMI 20-25 kg/m2 and at least 5% concomitant weight loss 
between current and previous recorded/reported weight. Low risk was for patients at low 
risk of undernutrition or obesity not in any of the above categories. 
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Table 1: Participants characteristics 
 Glasgow London  Athens Ioannina Total  
 65 135 100 90 390 
Mean (SD)      
Age, y 44.1 (17.6) 37.5 (13.2) 39.1 (13.1) 43.6 (15.7) 10.5 (9.5) 
Weight, kg 74.1 (15.2) 74.4 (16.6) 73.5 (15.2) 74.3 (16.6) 74.1 (16.0) 
Height, cm 169 (10) 170 (10) 170 (9.9) 171 (10) 170 (10) 
BMI, kg/m2 26.2 (5.2) 25.6 (5.0) 25.3 (4.6) 25.3 (4.5) 25.6 (4.8) 
Disease duration, y 11.1 (10.1) 10.9 (11.3) 10.7 (8.2) 9.0 (11.3) 10.5 (9.5) 
N (%)      
Gender      
Males 28 (43) 72 (53) 50 (50) 53 (59) 203 (52) 
Females 37 (57) 63 (47) 50 (50) 37 (41) 187 (48) 
Disease*      
UC 13 (20) 44 (32) 32 (32) 32 (32) 127 (33) 
CD 47 (72) 82 (61) 66 (67) 66 (67) 247 (63) 
IBDU 5 (8) 9 (7) 1 (1) 1 (1) 15 (4) 
Disease activity*      
Remission 32 (49) 61 (45) 64 (64) 58 (64) 215 (55) 
Moderate 24 (37) 38 (28) 19 (19) 18 (20) 99 (25) 
Active 9 (14) 36 (27) 17 (17) 14 (16) 76 (20) 
Medication      
Azathioprine* 33 (51) 41 (30) 24 (24) 41 (30) 139 (36) 
5-ASAs* 31 (48) 44 (33) 52 (52) 2 (2) 129 (33) 
Biologics* 20 (31) 42 (31) 30 (30) 57 (63) 149 (38) 
Oral steroids 9 (14) 17 (13) 12 (12) 6 (7) 44 (11) 
Vitamins/minerals* 15 (23) 71 (53) 24 (24) 5 (6) 115 (29) 
Nutritional supplements 2 (3) 7 (5) 3 (3) 0 (0) 12 (3) 
* p<0.05 between centres 
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